Member Detail - DF/HCC

Dr. Gregory Cote, MD

Claim this profile

Massachusetts General Hospital

Studies Cancer
Studies Soft Tissue Sarcoma
19 reported clinical trials
27 drugs studied

Area of expertise

1Cancer
Gregory Cote, MD has run 8 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
EGFR positive
2Soft Tissue Sarcoma
Gregory Cote, MD has run 7 trials for Soft Tissue Sarcoma. Some of their research focus areas include:
Stage IV
Stage III
archival tumor tissue

Affiliated Hospitals

Image of trial facility.
Massachusetts General Hospital
Image of trial facility.
Dana-Farber - Harvard Cancer Center LAO

Clinical Trials Gregory Cote, MD is currently running

More about Gregory Cote, MD

Clinical Trial Related7 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Gregory Cote, MD has experience with
  • Lurbinectedin
  • Nivolumab
  • Doxorubicin
  • Eribulin
  • Peposertib
  • Tuvusertib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Gregory Cote, MD specialize in?
Is Gregory Cote, MD currently recruiting for clinical trials?
Are there any treatments that Gregory Cote, MD has studied deeply?
What is the best way to schedule an appointment with Gregory Cote, MD?
What is the office address of Gregory Cote, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security